1240. Ceftobiprole Activity against Drug-Resistant Staphylococcus aureus Clinical Isolates Collected in the United States from 2016 through 2020

BACKGROUND: Multidrug-resistant (MDR) and methicillin-resistant Staphylococcus aureus (MRSA) present significant treatment challenges and can cause serious morbidity and mortality. Ceftobiprole, the active moiety of the prodrug ceftobiprole medocaril, is an advanced cephalosporin approved in many Eu...

Descripción completa

Detalles Bibliográficos
Autores principales: Duncan, Leonard R, Hamed, Kamal, Smart, Jennifer, Pfaller, Michael A, Sader, Helio S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644831/
http://dx.doi.org/10.1093/ofid/ofab466.1432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644831/
http://dx.doi.org/10.1093/ofid/ofab466.1432

Ejemplares similares